(Q44200362)

English

Helicobacter pylori infection in clinical practice: probiotics and a combination of probiotics + lactoferrin improve compliance, but not eradication, in sequential therapy

scientific article published on 20 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Helicobacter pylori infection in clinical practice: probiotics and a combination of probiotics + lactoferrin improve compliance, but not eradication, in sequential therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

0 references

Helicobacter pylori

1 reference

based on heuristic

inferred from title

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

author name string

Marco Manfredi

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Barbara Bizzarri

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Roberto Igino Sacchero

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sergio Maccari

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Lorenzo Calabrese

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Fabio Fabbian

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Gian Luigi De'Angelis

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

20 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

254-263

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

An African origin for the intimate association between humans and Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Eradication therapy for Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Helicobacter pylori eradication for gastric cancer prevention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

High eradication rates of Helicobacter pylori with a new sequential treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

"Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

High Helicobacter pylori numbers are associated with low eradication rate after triple therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Use of bovine lactoferrin for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Probiotics and Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Meta-analysis: the effect of supplementation with lactoferrin on eradication rates and adverse events during Helicobacter pylori eradication therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

The mechanism of action of probiotics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Irritable bowel syndrome, gut microbiota and probiotics.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

The intestinal microbiota and chronic disorders of the gut.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

From probiotics to therapeutics: another step forward?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Diagnosis of Helicobacter pylori infection: which is the best test? The stool test

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Lactobacilli for the management of Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Identification of the bactericidal domain of lactoferrin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Fresh thinking about the Declaration of Helsinki

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

A new highly effective short-term therapy schedule for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00944.X

21 January 2018

Identifiers

10.1111/J.1523-5378.2012.00944.X

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44200362&oldid=2108467653"